Publications in collaboration with researchers from Hospital de Fuenlabrada (38)

2024

  1. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project)

    Cancers, Vol. 16, Núm. 9

  2. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

  3. Textbook outcomes in the liver-first approach for colorectal liver metastases: prospective multicentre analysis

    BJS Open, Vol. 8, Núm. 1

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  2. Development and validation of a short version of the questionnaire of stressful life events (QSLE)

    Clinical Psychology and Psychotherapy, Vol. 30, Núm. 6, pp. 1464-1470

  3. Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

    Thrombosis Research, Vol. 228, pp. 181-188

  4. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

  5. Long-term outcomes in critically ill patients who survived COVID-19: The NUTRICOVID observational cohort study

    Clinical Nutrition, Vol. 42, Núm. 10, pp. 2029-2035

2022

  1. Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study

    Clinical Nutrition, Vol. 41, Núm. 12, pp. 2934-2939

  2. OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery

    Gynecologic Oncology, Vol. 167, Núm. 1, pp. 22-27

  3. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)

    European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141

  4. Quality of Life Impact of Hypoglossal Nerve Stimulation with Inspire® Device in Patients with Obstructive Sleep Apnea Intolerant to Continuous Positive Airway Pressure Therapy

    Life, Vol. 12, Núm. 11

  5. Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989

  2. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

    Cancer

2020

  1. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

    European heart journal, Vol. 41, Núm. 18, pp. 1720-1729

  2. Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

    Gynecologic Oncology Reports, Vol. 33

  3. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?

    Surgical Oncology, Vol. 33, pp. 19-23

  4. Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia

    Thrombosis Research, Vol. 195, pp. 139-145

  5. Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

    Breast, Vol. 54, pp. 286-292